Paul Whiteley/ LinkedIn
Jun 24, 2026, 17:36
Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
Paul Whiteley, Autism Researcher, shared a post on X about a recent article by Abdelaziz Hendy et al. published in Evidence-Based Nursing, adding:
” ‘All children with fetal neonatal alloimmune thrombocytopenia should have long-term structured neurodevelopmental and autism screening even if they do not have an intracranial haemorrhage (ICH)‘
Another one of the autisms.
And following an immune disorder.”
Title: Are higher autism rates in FNAIT without intracranial haemorrhage real or a result of increased screening?
Authors: Abdelaziz Hendy, Abdulqadir J Nashwan
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience